RO offering Eli Lilly's Foundayo
Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary.
Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary.
The most effective GLP-1 medication is now available in a multi-dose pen.
The Wegovy injectable and pill are now available at even lower cash pay prices on Ro.
Super Bowl ad highlights the health benefits Williams has experienced on Ro and marks the launch of a new multi-channel national campaign starring real Ro patients.
Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.